QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in
LON:BXP

Beximco Pharmaceuticals Limited (BXP.L) Share Forecast, Price & News

GBX 93
+0.50 (+0.54 %)
(As of 01/26/2021 05:07 PM ET)
Add
Compare
Today's Range
90.02
Now: GBX 93
97
50-Day Range
80
MA: GBX 97.29
107
52-Week Range
28.07
Now: GBX 93
110
Volume38,896 shs
Average Volume162,224 shs
Market Capitalization£414.88 million
P/E RatioN/A
Dividend Yield1.38%
BetaN/A
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.
Beximco Pharmaceuticals Limited (BXP.L) logo

MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+880-2-58611001
Employees4,500
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap£414.88 million
Next Earnings DateN/A
OptionableOptionable
GBX 93
+0.50 (+0.54 %)
(As of 01/26/2021 05:07 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BXP News and Ratings via Email

Sign-up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Beximco Pharmaceuticals Limited (BXP.L) (LON:BXP) Frequently Asked Questions

How has Beximco Pharmaceuticals Limited (BXP.L)'s stock been impacted by Coronavirus (COVID-19)?

Beximco Pharmaceuticals Limited (BXP.L)'s stock was trading at GBX 39 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BXP shares have increased by 138.5% and is now trading at GBX 93.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Beximco Pharmaceuticals Limited (BXP.L)?

Wall Street analysts have given Beximco Pharmaceuticals Limited (BXP.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Beximco Pharmaceuticals Limited (BXP.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is Beximco Pharmaceuticals Limited (BXP.L) a good dividend stock?

Beximco Pharmaceuticals Limited (BXP.L) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 1.38%.
View Beximco Pharmaceuticals Limited (BXP.L)'s dividend history.

Who are some of Beximco Pharmaceuticals Limited (BXP.L)'s key competitors?

Who are Beximco Pharmaceuticals Limited (BXP.L)'s key executives?

Beximco Pharmaceuticals Limited (BXP.L)'s management team includes the following people:
  • Mr. Nazmul Hassan, MD & Director
  • Mr. Mohammad Ali Nawaz, Chief Financial Officer
  • Mr. Rabbur Reza, Chief Operating Officer
  • Mr. Jamal Ahmed Choudhury, Exec. Director of Accounts & Fin.
  • Mr. Rizvi Ul Kabir, Director of Marketing
  • Mr. M. A. Arshad Bhuiyan, Gen. Mang. of HR
  • Mr. Zakaria Seraj Chowdhury, Head of Distribution Services & Director of International Marketing
  • Mr. Prabir Ghose, Exec. Director of Quality Assurance

What is Beximco Pharmaceuticals Limited (BXP.L)'s stock symbol?

Beximco Pharmaceuticals Limited (BXP.L) trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

How do I buy shares of Beximco Pharmaceuticals Limited (BXP.L)?

Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Beximco Pharmaceuticals Limited (BXP.L)'s stock price today?

One share of BXP stock can currently be purchased for approximately GBX 93.

How big of a company is Beximco Pharmaceuticals Limited (BXP.L)?

Beximco Pharmaceuticals Limited (BXP.L) has a market capitalization of £414.88 million. Beximco Pharmaceuticals Limited (BXP.L) employs 4,500 workers across the globe.

What is Beximco Pharmaceuticals Limited (BXP.L)'s official website?

The official website for Beximco Pharmaceuticals Limited (BXP.L) is www.beximco-pharma.com.

How can I contact Beximco Pharmaceuticals Limited (BXP.L)?

Beximco Pharmaceuticals Limited (BXP.L)'s mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The company can be reached via phone at +880-2-58611001.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.